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 Abstract  1 
Objectives  To identify whether the lncRNAs participate in the regulation of cisplatin-resistant induced 2 
autophagy in endometrial cancer cells. 3 
Results  Autophagy assay showed that autophagy activity was significantly boosted in cisplatin-resistant 4 
Ishikawa cells, a human endometrial cancer cell line, compared with that in parental Ishikawa cells. After 5 
analyzing the overall long noncoding RNA (lncRNA) profiling, a meaningful lncRNA, HOTAIR, was 6 
identified. It was down-regulated simultaneously in cisplatin-resistant Ishikawa cells and parental 7 
Ishikawa cells treated by cisplatin. RNA interference of HOTAIR reduced the proliferation of 8 
cisplatin-resistant Ishikawa cells and enhanced the autophagy activity of cisplatin-resistant Ishikawa cells 9 
with or without cisplatin treatment. And beclin-1, multidrug resistance (MDR), and P-glycoprotein (P-gp) 10 
were mediated by lncRNA HOTAIR. 11 
Conclusions  It is clear that lncRNAs, specifically HOTAIR, can regulate the cisplatin-resistance ability 12 
of human endometrial cancer cells through regulation of autophagy by influencing Beclin-1, MDR, and 13 
P-gp expression. 14 









 Introduction 1 
One of uterine cancers, endometrial cancer, is the common gynecologic malignancies worldwide. 2 
Currently, cisplatin, one of platinum compounds, is regarded as the first line drugs to treat endometrial 3 
cancer in either adjuvant or neo-adjuvant settings. Although cisplatin-based treatment prolongs the cancer 4 
progression-free intervals, the actual survival is unaltered, which dues to the development of 5 
chemoresistance. Therefore, to effectively control the endometrial cancer, the novel objective is focused 6 
on resolving the problem of chemoresistance. 7 
Autophagy is a major cellular process that captures intracellular organelles and cytoplasmic 8 
materials in autophagosomes, and delivers them to the lysosomal compartment where they are degraded 9 
and recycled (Mizushima 2010). Recently, accumulating reports have revealed that autophagy was 10 
utilized to mediate the chemoresistance (Sui et al. 2013). Particularly, one of mechanisms of 11 
cisplatin-resistance in ovarian and endometrial cancer was demonstrated to correlate with autophagy 12 
(Fukuda et al. 2015). However, the detailed contributions of autophagy to cisplatin-resistant endometrial 13 
cancer remain extremely limited. 14 
Some references suggest that many long noncoding RNA (lncRNA) have a role in mediating the 15 
chemoresistance of cancer cells (Liu et al. 2015; Liu et al. 2013). But the underlying mechanisms are less 16 
well documented, and whether lncRNA participates in the regulation of chemoresistance-induced 17 
autophagy in endometrial cancer remains unknown. 18 
Herein, a meaningful lncRNA, HOTAIR, was identified and evidenced to be a tumor chemoresistant 19 
promoter. It’s mechanism of regulating autophagy contributing to the cisplatin-induced resistance in 20 
endometrial cancer cells was investigated. 21 
Methods 22 
Cell culture and treatment 23 
 The Ishikawa human endometrial cancer cell line and its cisplatin-resistant sub-clone were used in the in 1 
vitro studies. For cisplatin treatment, both cell lines were seeded into 96-well plates at a rate of 2×103 2 
cells/well and incubated with DMEM containing various concentrations of cisplatin (0-80 μg/ml) for 3 
indicated times.  4 
Autophagy assay using the DsRed-LC3-GFP reporter 5 
To develop a dual-color autophagy reporter, we used ptfLC3 (Addgene plasmid 21074), which is a 6 
mRFP-green fluorescence protein (GFP) tandem fluorescent-tagged LC3 (also known as ATG8) plasmid 7 
that DsRed protein is fused with N terminus of LC3 protein and C terminus of the protein is connected to 8 
EGFP. To produce stable cell lines continuously reporting autophagy activity, recombinant retroviruses 9 
expressing the DsRed-LC3-GFP reporter were generated and used to infect target cells. 10 
LncRNA profiling 11 
To identify the involved lncRNAs, Human Disease-related LncRNA Profiler (System Biosciences) was 12 
utilized and overall lncRNAs were selected from the RNA database 13 
(http://research.imb.uq.edu.au/rnadb/Default.aspx) or lncRNA database (www.lncRNAdb.org). Total 14 
RNA was extracted from Ishikawa human endometrial cancer cell line and its cisplatin-resistant sub-clone 15 
pretreated with or without cisplatin. Reverse transcription was carried out by using RevertAidTM Reverse 16 
Transcriptase (Fermentas) and random primer mix (New England BioLabs). The values for the cells 17 
without treatment after normalization by the internal controls served as a basal level of expression of 18 
indicated lncRNAs; delta-delta Ct values (no treatment versus carboplatin plus docetaxel treatment) were 19 
used to determine their relative expression as fold changes.  20 
Cell proliferation assay 21 
 Cell proliferation was analyzed by using CCK-8 assay kit (Dojindo) according to manufacturer 1 
indications. In particular, cells were respectively incubated in the medium containing cisplatin in the 2 
absence or presence of small interference RNA (siRNA) against HOTAIR in 96-well plates for indicated 3 
times. After that, 5µl CCK-8 reagent was added to each well and incubated at 37 °C for 1 h. The cell 4 
numbers were assessed by measurement of absorbance at 450 nm. All the experiments were performed in 5 
triplicate. 6 
RNA interference 7 
The sequences of siRNA corresponding to lncRNA HOTAIR was synthesized (Qiagen). Ishikawa human 8 
endometrial cancer cell line and its cisplatin-resistant sub-clone were respectively transfected with three 9 
HOTAIR siRNAs (100 nM) using Lipofectamine 2000 (Invitrogen) according to the manufacturer’s 10 
specifications. Scrambled siRNA was used as negative control. Post-transfection later, cells were 11 
respectively collected for CCK-8 assay. 12 
Western blotting 13 
The expression levels of proteins were determined by western blotting using the enhanced 14 
chemiluminescent substrate (ECL, BioRad, Richmond, CA, USA) in accordance with the manufacturer’s 15 
instruction. 16 
Statistical analysis 17 
All data were expressed as mean ± standard deviation (SD) and subjected to analysis of variance 18 
(ANOVA) to assess the treatment effects by using SPSS 13.0 software. The Student’s t-test was used to 19 
determine the statistically significant differences in numbers with two significant levels (0.05 and 0.01). 20 
Results 21 
Identification of cisplatin-resistant Ishikawa human endometrial cancer cell line 22 
 A CCK8-based proliferation assay was used to investigate the growth suppressive effect of cisplatin (CP) 1 
on Ishikawa and its resistant cell line (Ishikawa CP). Treatment with cisplatin inhibited cell proliferation 2 
in a dose-dependent manner, in which the cell viability of Ishikawa CP is obviously higher than its 3 
sensitive cell line (Fig. S1a). Moreover, the half-maximal inhibitory concentration (IC50) values were 4 
approximately 20 and 60 μg/ml for Ishikawa and its resistant cell line (Fig. S1b). These findings suggest 5 
that the cisplatin-resistant Ishikawa cell sub-clone was selected.   6 
Ishikawa CP shows higher autophagy  7 
To examine whether Ishikawa CP possesses the increased autophagy, a dual color DsRed-LC3-GFP 8 
reporter was used, which is modiﬁed formation of the classical GFP-tagged LC3 reporter introducing two 9 
readouts for autophagy activity. The reporter has GFP separated from the C terminus of LC3 by a 10 
recognition site for the autophagic protease, ATG4, and fewer of GFP ﬂuorescence means the increased 11 
autophagy. Ishikawa CP presented a significantly reduced GFP ﬂuorescence in contrast to normal 12 
Ishikawa cells, indicating the abnormal autophagy activity in Ishikawa CP (Fig. 1a). Additionally, the 13 
more autophagosomes were detected in Ishikawa CP (Fig. 1b). These data suggest that higher autophagy 14 
is likely to positively involve the cisplatin resistance in Ishikawa CP.  15 
Differential expression of lncRNAs between Ishikawa CP and normal Ishikawa cell 16 
Next, whether lncRNAs involved in altered autophagy of Ishikawa CP was investigated. The expression 17 
of lncRNAs in normal Ishikawa and Ishikawa CP with or without CP treating was detected, 18 
Tumor-related lncRNAs were selected to analysis, and most of these lncRNAs expression had been 19 
changed in these four experimental groups (Fig. S2a). Among these differential lncRNAs, HOTAIR 20 
presents the less expression in Ishikawa CP, and Ishikawa and Ishikawa CP in presence of CP treatment 21 
in contrast to normal Ishikawa (Fig. S2b). Although the least expression of lncRNA HOTAIR was shown 22 
in Ishikawa CP in absence and presence of CP, the expression of lncRNA HOTAIR in these two groups 23 
 was identical (Fig. S2b), indicating that CP treatment impossibly changes the expression of HOTAIR in 1 
Ishikawa CP.  2 
HOTAIR ensures higher proliferation of Ishikawa CP in CP treatment 3 
To examine the mechanism that links HOTAIR to the CP-resistant activity of Ishikawa CP, HOTAIR was 4 
knocked down by using RNA interference technique. Primarily, three HOTAIR siRNA were selected, and 5 
endogenous HOTAIR mRNA level was analyzed by RT-PCR and detected to be lower in HOTAIR 6 
siRNA2-transfected cells as compared to cells transfected with scrambled siRNA control, demonstrating 7 
the effectiveness of HOTAIR siRNA2 (Fig. 2a). Since treating with CP suppressed the expression of 8 
HOTAIR and Ishikawa CP showed the fewer expression of HOTAIR, the effect of HOTAIR inhibition on 9 
anti-CP resistant action was analyzed. Interestingly, the HOTAIR siRNA-transfected cells (including 10 
normal Ishikawa and Ishikawa CP) have a specific reduction in cell proliferation as compared to the 11 
control-transfected cells through CCK-8 assay (Fig. 2b).  12 
Higher autophagy of Ishikawa CP is dependent on LncRNA HOTAIR 13 
Using the decrease of GFP fluorescence intensity as readout for enhanced autophagy, we detected that 14 
HOTAIR siRNA treatment did not impact the autophagy activity in Ishikawa, but improved the autophagy 15 
action in Ishikawa in presence of CP incubation. In contrast, HOTAIR siRNA markedly induced the 16 
autophagy activity in Ishikawa CP in absence or presence of CP treatment (Fig. 3). These observations 17 
indicate that a CP resistance-related lncRNA, HOTAIR, play a significantly positive role in autophagy 18 
activity in endometrial cancer.  19 
LncRNA HOTAIR regulates the expression of autophagy regulator, Beclin-1 20 
Given the positive inter-relationship between autophagy activity and HOTAIR expression, the expression 21 
of autophagy regulator, Beclin-1, was measured by using HOTAIR siRNA. In normal, Ishikawa CP 22 
 represented higher expression of Beclin-1 than Ishikawa cells, and HOTAIR siRNA dramatically 1 
down-regulated the expression of Beclin-1 in both cell lines. Upon the CP treatment, significantly more 2 
expression of Beclin-1 was observed in Ishikawa CP cells compared with that in Ishikawa cells. Moreover, 3 
HOTAIR siRNA treatment resulted in decreases in Beclin-1 expression in Ishikawa CP cells (Fig. 4). 4 
These results demonstrate that HOTAIR may control the autophagy activity of endometrial cancer by 5 
mediating the expression of Beclin-1. 6 
LncRNA HOTAIR regulates the expression of MDR and P-gp 7 
To assess the potential interaction between HOTAIR and resistance-related proteins, the expression level 8 
of MDR and P-gp in Ishikawa and Ishikawa CP cells with or without transfection with HOTAIR siRNA 9 
was examined by Western blot analysis (Fig. 4). Originally, Ishikawa CP cells highly expressed MDR and 10 
P-gp. After incubating with CP only, the expressions of these two proteins were up-regulated in both 11 
Ishikawa cell lines. Upon the HOTAIR siRNA transfection only, the protein levels of MDR and P-gp were 12 
significantly reduced in Ishikawa CP cells. When integrated administration of CP and HOTAIR siRNA, 13 
MDR, and P-gp presented the declined protein level in both Ishikawa cell lines in contrast to that in only 14 
CP treatment, thereby eliciting a possible that transfection with HOTAIR siRNA in Ishikawa CP cells has 15 
made it partially sensitive to cisplatin because of decreased MDR and P-gp expression.  16 
Discussion 17 
Cisplatin is a commonly used chemotherapy drug and is the first chemotherapeutic choice for endometrial 18 
cancer. However, acquired cisplatin resistance is the greatest obstacle to clinical chemotherapy. In this 19 
study, we found that the HOTAIR expression level was significantly decreased in cisplatin-resistant 20 
Ishikawa CP cell compared with parental Ishikawa cells. The HOTAIR inhibition appeared to reverse the 21 
chemoresistance of Ishikawa CP cells to cisplatin. HOTAIR appeared to function as a tumor 22 
chemoresistant promoter by regulating the expression of Beclin-1, MDR, and P-glycoprotein. 23 
 HOTAIR, with a length of 2158 bp, is one of the few biologically well-defined lncRNAs and 1 
functions on the regulation of trans-silencing (Woo and Kingston 2007). HOTAIR has been found to be 2 
highly expressed in many kinds of human cancers and identified to be a negative prognostic indicator in 3 
colon, liver, breast, and pancreatic cancer patient survival, thereby evidencing a close association with 4 
increase in cancer cell metastasis (Kim et al. 2013; Kogo et al. 2011). Additional new report is now 5 
providing evidence to indicate that HOTAIR is important in regulating the expression of genes involved 6 
in cisplatin resistance of human lung adenocarcinoma cells (Liu et al. 2013). Similarly, our present study 7 
found that HOTAIR contributes to the resistance of endometrial cancer to cisplatin, and HOTAIR 8 
inhibition increases the autophagy in vitro. Previous studies did not reveal how any lncRNA might be 9 
responsible for autophagy-related chemoresistance. In current, we show that HOTAIR contributes to the 10 
cisplatin resistance of Ishikawa CP cells through autophagy pathway, demonstrating a mechanistic link 11 
among HOTAIR, autophagy, and cisplatin resistance in endometrial cancer. The cisplatin resistance 12 
regulated by autophagy and autophagy regulated by lncRNA have been extensively documented in the 13 
literature (Liu et al. 2015; Wang and Wu 2014). However, the ability of lncRNA to reverse 14 
chemoresistance through regulation of autophagy activity and in turn inhibit proliferation in endometrial 15 
cancer was previously unrecognized.  16 
Previous study reported that HOTAIR worked together with the PRC2 and LSD1/CoREST/REST, 17 
which causes the modifications of DNA-binding proteins and eventually regulates overall gene 18 
expressions (Chang and Hung 2012; Cao et al. 2012; Semaan et al. 2011; Murati et al. 2012 ). In 19 
HOTAIR-induced cisplatin resistance of lung adenocarcinoma cells, p21 might be an important mediator 20 
(Liu et al. 2013). In the present study, transfection of HOTAIR1 siRNA could significantly decline the 21 
increased expression of Beclin-1, MDR, and P-gp in Ishikawa CP cells, indicating that Beclin-1, MDR, 22 
and P-gp were the downstream targets of HOTAIR. Certainly, the molecular mechanisms involved in 23 
HOTAIR-induced Beclin-1, MDR, and P-gp down-regulation need to be further elucidated in future.  24 
 In summary, we have clearly lucubrated that lncRNAs, specifically HOTAIR, can regulate the 1 
cisplatin-resistance ability of human endometrial cancer cells through regulation of autophagy by 2 
influencing Beclin-1, MDR, and P-gp expression. Our study provides the new clues and valuable 3 
information towards development of a complete understanding of the pathogenesis and development of 4 
the cisplatin resistance in human endometrial cancer. This raises the possibility that anti-HOTAIR may 5 
have potential therapeutic value for those cisplatin-resistant endometrial cancer patients. 6 
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